treosulfan has been researched along with Hemolysis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giebel, S; Hołowiecki, J; Krawczyk-Kuliś, M; Markiewicz, M; Mendek-Czajkowska, E; Wojciechowska, M; Wojnar, J; Woźniczka, K; Wylezoł, I | 1 |
1 other study(ies) available for treosulfan and Hemolysis
| Article | Year |
|---|---|
Unrelated donor bone marrow transplantation with treosulfan-based myeloablative conditioning for paroxysmal nocturnal hemoglobinuria--successful treatment despite multiple transplant-related risk factors for hemolysis including major Kidd group incompatib
Topics: Adult; Antineoplastic Agents, Alkylating; Blood Group Incompatibility; Bone Marrow Transplantation; Busulfan; Hemoglobinuria, Paroxysmal; Hemolysis; Histocompatibility; Humans; Kidd Blood-Group System; Living Donors; Male; Risk Factors; Transplantation Conditioning | 2006 |